Characterisation of novel Aquaporin channel blockers for treatments of brain oedema and cancer


The Aquaporin Research Program is testing novel blocking agents designed by Professor Andrea Yool and her research team, as tools to inhibit the migration of aggressive cancers such as colon cancer and glioblastoma, and to improve treatment of brain oedema after injury.

Date & time

1–2pm 19 June 2014


Slatyer Seminar Room,
R.N. Robinson Building (Bldg 46),
Cunningham Close, ANU


Professor Andrea Yool, University of Adelaide


 Rowena Martin
 02 619 70051

Updated:  17 November 2018/Responsible Officer:  Director RSB/Page Contact:  Webmaster RSB